Home page Company name and slogan

Stock Recommendation Results

Consistent Winner of Hulbert's #1 Rank!

Custom Search
Investment Newsletters Best Fidelity Funds Best ETFs Get Free Reports 10-Year Journey Blog

Stock Recommendation Results

AlphaProfit MoneyMatters Investing Blog RSS Feed

Enabling You to Earn Exciting Returns from Stocks

Dec. 31, 2008 to Sep. 21, 2018

Performance of Filled Recommendations

Win Rate: 86%

Avg. Return: 12.2%

Avg. Holding Period: 2 months

Implied Annualized Return: 86%


Sign up for AlphaProfit's FREE Stock Newsletter and immediately receive Two Special Reports:

  • 5 Smart Ways to Invest in Sector Funds & ETFs
  • Avoid 3 Common Mistakes ETF Investors Make

Sign up for Free Stock Newsletter

The results reported here are based on EXACT buy and sell price points AlphaProfit provides with each stock recommendation making results easily verifiable. The reported returns assume reinvestment of dividends; they do not account for brokerage commission expenses.

To provide you reliable winning stock recommendations, AlphaProfit puts stocks under the microscope.

Leaving nothing to chance, AlphaProfit evaluates stocks on both fundamental and technical factors ... fundamentals to make sure that companies are worthy of committing your precious dollars from quality, valuation, and growth perspectives, and technicals to provide you laser-cut buy and sell price points.

'I do not know of any other service that makes stock investing so easy and is always on target. I have made quite a bundle with the precise buy and sell price points your stock recommendations include.'

William C., Chapel Hill, NC

Stock Newsletter

Additionally, each recommended stock has a unique catalyst that speeds the time you need to realize your profit and at the same time ... reduces your risk.

The result ... you go from winner to winner rapidly growing your money.

The stock recommendations supplement AlphaProfit's ETF and mutual fund recommendations providing you multiple ways to make money.

Examples of Stock Recommendations and Results

Western Digital (WDC)

What AlphaProfit Said

Buy Below: $82.65       Sell Above: $94.30

Western Digital's legal battle with Toshiba over the latter's plan to sell a unit that makes memory chips for a JV between the two firms is weighing on the former's shares. The concern is a buying opportunity since the unit's new owners are likely to maintain its leadership in future. Meanwhile, Western Digital is poised to benefit from favorable demand and pricing for storage devices used in smartphones and data centers. Its shares interest value as well as growth investors. They yield 2.5% and trade at 6.4X-forward EPS versus prospects for 36% growth in EPS in the next 12 months. (Next earnings: Late October).

What Subscribers Got

18% Profit

Bought at $80.93 on Aug. 14, 2017

Sold at $94.30 on Mar. 7, 2018

Holding Period 7 months

Smart Sand (SND)

What AlphaProfit Said

Buy Below: $8.35       Sell Above: $11.00

The past quarter was Smart Sand's best ever. The producer of frac sands used to enhance hydrocarbon recovery rates from wells earned 17 cents a share, crushing analysts' forecast by nearly 70%. Revenues rose 260% year-over-year as sand tons sold grew 184% from operational improvements at its Oakdale, WI mine. The Oakdale mine's annual capacity should increase from 3.3 million tons to 5.5 million tons next quarter. Volatile Smart Sand shares interest venturesome growth investors. They trade 10.6X-forward EPS versus prospects for nearly 40% EPS growth annually for the next five years. (Next earnings: Mid-March 2018)

What Subscribers Got

32% Profit

Bought at $8.35 on Dec. 20, 2017

Sold at $11.00 on Jan. 11, 2018

Holding Period 3 weeks

CVS Health (CVS)

What AlphaProfit Said

Buy Below: $68.75       Sell Above: $77.50

CVS Health expects regulators to approve its $69 billion purchase of Aetna before year-end, making CVS one of the most vertically integrated healthcare companies. CVS has announced the merged entity's management and set up an integration team after shareholders approved the deal. Ahead of the merger, CVS by itself is executing well. It beat analysts' first-quarter EPS estimate by 5% and raised its 2018 EPS forecast range to imply 18% growth at the mid-point. Yielding 3.0%, CVS shares interest value investors. They trade at 9.6X-2018 EPS forecast, well-below their historical multiple. (Next earnings: Aug 8)

What Subscribers Got

18% Profit

Bought at $66.35 on Jun. 12, 2018

Sold at $77.50 on Sep. 10, 2018

Holding Period 3 months

More Stock Recommendations & Results

Related Links:
Stock Newsletter

Sam Subramanian



Protect & grow your wealth with
stock recommendations from free e-letter
AlphaProfit MoneyMatters

By Hulbert #1 rank winner Dr. Sam Subramanian

'Incisive Insights, Impressive Results'   - Jim Woodruff

First Name:

Email Address:

We respect your privacy. We will not spam or sell your information to others, period.

Subscribe to the AlphaProfit Investment Newsletter now!

Custom Search

This page is best viewed in 1024 by 768 pixels screen resolution or higher.
Copyright © 2013 AlphaProfit Investments, LLC. All rights reserved.